Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
Citizen advocates push the pharmaceutical company to examine a compound that has been used to treat certain coronavirus infections in cats.
Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug
Gilead Urged to Explore Remdesivir Relative as COVID-19 Drug

Citizen advocates push the pharmaceutical company to examine a compound that has been used to treat certain coronavirus infections in cats.

Citizen advocates push the pharmaceutical company to examine a compound that has been used to treat certain coronavirus infections in cats.

remdesivir
Remdesivir Shows Promise in Largest of Several Clinical Trials
Remdesivir Shows Promise in Largest of Several Clinical Trials
Catherine Offord | Apr 30, 2020
Gilead’s experimental antiviral drug shortened the average time it took COVID-19 patients to recover in a NIAID-sponsored trial. There was weak evidence that it also helped reduce deaths.